102 related articles for article (PubMed ID: 12624533)
1. Mechanisms involved in glucagon-like peptide-1 (7-36) amide action on the rat hypothalamo-neurohypophysial system.
Bojanowska E; Stempniak B
Neuroendocrinology; 2003 Feb; 77(2):119-24. PubMed ID: 12624533
[TBL] [Abstract][Full Text] [Related]
2. tGLP-1 and release of vasopressin and oxytocin from the isolated rat hypothalamo-neurohypophysial system: effects of a tGLP-1 receptor agonist and antagonist.
Bojanowska E; Stempniak B
J Physiol Pharmacol; 2001 Dec; 52(4 Pt 2):781-93. PubMed ID: 11785773
[TBL] [Abstract][Full Text] [Related]
3. tGLP-1 action on the isolated hypothalamo-neurohypophysial system under glutamate receptor blockade.
Bojanowska E; Stempniak B
Brain Res Bull; 2002 Sep; 58(6):555-9. PubMed ID: 12372558
[TBL] [Abstract][Full Text] [Related]
4. Effects of tGLP-1 on feeding behaviour and neurohypophysial function under chronic osmotic stimulation.
Bojanowska E; Stempniak B
Physiol Behav; 2003 Jan; 78(1):73-9. PubMed ID: 12536013
[TBL] [Abstract][Full Text] [Related]
5. Effects of glucagon-like peptide-1(7-36) amide on neurohypophysial and cardiovascular functions under hypo- or normotensive hypovolaemia in the rat.
Bojanowska E; Stempniak B
J Endocrinol; 2002 Feb; 172(2):303-10. PubMed ID: 11834448
[TBL] [Abstract][Full Text] [Related]
6. Forskolin-stimulated vasopressin and oxytocin release from the rat hypothalamo-neurohypophysial system in vitro is inhibited by melatonin.
Roszczyk M; Juszczak M
Endokrynol Pol; 2014; 65(2):125-31. PubMed ID: 24802736
[TBL] [Abstract][Full Text] [Related]
7. Effects of glucagon and glucagon-like peptide-1-(7-36) amide on C cells from rat thyroid and medullary thyroid carcinoma CA-77 cell line.
Crespel A; De Boisvilliers F; Gros L; Kervran A
Endocrinology; 1996 Sep; 137(9):3674-80. PubMed ID: 8756532
[TBL] [Abstract][Full Text] [Related]
8. Neurokinin A and the neurohypophysial response to melatonin: in vitro studies.
Juszczak M
J Physiol Pharmacol; 2002 Dec; 53(4 Pt 2):823-34. PubMed ID: 12510866
[TBL] [Abstract][Full Text] [Related]
9. Hypothalamic gonadotropin-releasing hormone receptor activation stimulates oxytocin release from the rat hypothalamo-neurohypophysial system while melatonin inhibits this process.
Juszczak M; Boczek-Leszczyk E
Brain Res Bull; 2010 Jan; 81(1):185-90. PubMed ID: 19874874
[TBL] [Abstract][Full Text] [Related]
10. Vasopressin and oxytocin regulation of cyclic AMP accumulation in rat hypothalamo-neurohypophysial explants in vitro.
Meeker RB; Michels KM; Hayward JN
Neurosci Lett; 1990 Jul; 114(2):225-30. PubMed ID: 2168530
[TBL] [Abstract][Full Text] [Related]
11. The role of the cAMP/PKA signalling pathway in the inhibitory influence of melatonin on oxytocin and vasopressin secretion from the rat hypothalamo-neurohypophysial system.
Juszczak M; Krzyminska A; Bojanowska E; Roszczyk M
Endokrynol Pol; 2018; 69(5):560-566. PubMed ID: 30074234
[TBL] [Abstract][Full Text] [Related]
12. Effects of glucagon-like peptide-1 (7-36) amide on neurohypophysial hormone secretion induced by acute hyperosmotic challenge.
Bojanowska E; Stempniak B
Neuropeptides; 2003 Feb; 37(1):45-50. PubMed ID: 12637035
[TBL] [Abstract][Full Text] [Related]
13. Galanin and galanin-like peptide modulate vasopressin and oxytocin release in vitro: the role of galanin receptors.
Wodowska J; Ciosek J
Neuropeptides; 2014 Dec; 48(6):387-97. PubMed ID: 25464889
[TBL] [Abstract][Full Text] [Related]
14. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
Larsen PJ; Tang-Christensen M; Jessop DS
Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
[TBL] [Abstract][Full Text] [Related]
15. Effects of centrally or systemically injected glucagon-like peptide-1 (7-36) amide on release of neurohypophysial hormones and blood pressure in the rat.
Bojanowska E; Stempniak B
Regul Pept; 2000 Jul; 91(1-3):75-81. PubMed ID: 10967203
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line.
Gros L; Thorens B; Bataille D; Kervran A
Endocrinology; 1993 Aug; 133(2):631-8. PubMed ID: 8102095
[TBL] [Abstract][Full Text] [Related]
17. The third cytoplasmic domain of the GLP-1[7-36 amide] receptor is required for coupling to the adenylyl cyclase system.
Takhar S; Gyomorey S; Su RC; Mathi SK; Li X; Wheeler MB
Endocrinology; 1996 May; 137(5):2175-8. PubMed ID: 8612565
[TBL] [Abstract][Full Text] [Related]
18. Galanin modulates oxytocin release from rat hypothalamo-neurohypophysial explant in vitro - the role of acute or prolonged osmotic stimulus.
Ciosek J; Drobnik J
Endokrynol Pol; 2013; 64(2):139-48. PubMed ID: 23653277
[TBL] [Abstract][Full Text] [Related]
19. Luteinizing hormone-releasing hormone and function of the magnocellular vasopressinergic system.
Bojanowska E; Guzek JW; Dabrowski R
Neuropeptides; 1999 Aug; 33(4):301-5. PubMed ID: 10657507
[TBL] [Abstract][Full Text] [Related]
20. [Influence of thyroliberin on vasopressin and oxytocin release from the hypothalamo-neurohypophysial system under in vivo and in vitro conditions].
Ciosek J
Postepy Hig Med Dosw (Online); 2007 Jul; 61():429-37. PubMed ID: 17679913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
